ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.645
      -0.17%
      Bitcoin
      65,069.67
      -0.11%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Galapagos (GLPG)

      7. Galapagos (GLPG) News

      GLPG

      Galapagos (GLPG)

      Galapagos
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:GLPG
      DateTimeSourceHeadlineSymbolCompany
      11/09/20204:01PMGlobeNewswire Inc.First patient dosed with GLPG3667 in psoriasis patient Phase 1b trialEU:GLPGGalapagos
      11/09/20204:01PMGlobeNewswire Inc.First patient dosed with GLPG3667 in psoriasis patient Phase 1b trialEU:GLPGGalapagos
      11/05/20204:15PMGlobeNewswire Inc.OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosisEU:GLPGGalapagos
      11/05/20204:15PMGlobeNewswire Inc.OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosisEU:GLPGGalapagos
      11/05/20204:01PMGlobeNewswire Inc.Galapagos reports Q3 2020 resultsEU:GLPGGalapagos
      11/05/20204:01PMGlobeNewswire Inc.Galapagos reports Q3 2020 resultsEU:GLPGGalapagos
      11/02/20204:01PMGlobeNewswire Inc.EUROPEAN  MEDICINES  AGENCY  VALIDATES  MARKETING  APPLICATION  FOR  FILGOTINIB  FOR  THE  TREATMENT  OF  ULCERAT...EU:GLPGGalapagos
      11/02/20204:01PMGlobeNewswire Inc.EUROPEAN  MEDICINES  AGENCY  VALIDATES  MARKETING  APPLICATION  FOR  FILGOTINIB  FOR  THE  TREATMENT  OF  ULCERAT...EU:GLPGGalapagos
      10/27/202011:20AMGlobeNewswire Inc.Galapagos’ R&D Roundtable showcases Toledo programEU:GLPGGalapagos
      10/27/202011:20AMGlobeNewswire Inc.Galapagos’ R&D Roundtable showcases Toledo programEU:GLPGGalapagos
      10/15/20205:17PMDow Jones NewsGalapagos, Servier Knee Osteoarthritis Trial Fails to Meet Primary, Secondary EndpointsEU:GLPGGalapagos
      10/15/20204:19PMGlobeNewswire Inc.Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis...EU:GLPGGalapagos
      10/15/20204:19PMGlobeNewswire Inc.Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis...EU:GLPGGalapagos
      10/12/202010:06AMDow Jones NewsGilead, Galapagos See Sustained Efficacy, Safety for FilgotinibEU:GLPGGalapagos
      09/29/20204:01PMGlobeNewswire Inc.Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trialEU:GLPGGalapagos
      09/29/20204:01PMGlobeNewswire Inc.Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trialEU:GLPGGalapagos
      09/25/20201:00PMGlobeNewswire Inc.EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS...EU:GLPGGalapagos
      09/25/20201:00PMGlobeNewswire Inc.EUROPEAN  COMMISSION  GRANTS  MARKETING  AUTHORIZATION FOR JYSELECA® (FILGOTINIB)  FOR  THE  TREATMENT  OF  ADULTS...EU:GLPGGalapagos
      09/25/20202:13AMGlobeNewswire Inc.Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritisEU:GLPGGalapagos
      09/25/20202:13AMGlobeNewswire Inc.Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritisEU:GLPGGalapagos
      09/25/20202:00AMGlobeNewswire Inc.Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritisEU:GLPGGalapagos
      09/25/20202:00AMGlobeNewswire Inc.Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritisEU:GLPGGalapagos
      09/18/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      09/18/20204:01PMGlobeNewswire Inc.Galapagos increases share capital through subscription right exercisesEU:GLPGGalapagos
      09/14/20201:16AMDow Jones NewsGilead va racheter la biotech Immunomedics pour 21 milliards de dollarsEU:GLPGGalapagos
      09/10/202010:30PMGlobeNewswire Inc.Primary endpoint achieved with ziritaxestat  in NOVESA trial in systemic sclerosis patientsEU:GLPGGalapagos
      09/10/202010:30PMGlobeNewswire Inc.Primary endpoint achieved with ziritaxestat  in NOVESA trial in systemic sclerosis patientsEU:GLPGGalapagos
      08/26/20201:30AMGlobeNewswire Inc.Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress   ...EU:GLPGGalapagos
      08/26/20201:30AMGlobeNewswire Inc.Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress   ...EU:GLPGGalapagos
      08/19/20208:24AMDow Jones NewsGalapagos, Gilead Shares Fall as FDA Seeks More Filgotinib DataEU:GLPGGalapagos
       Showing the most relevant articles for your search:EU:GLPG